METTL4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.328800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.567600E-01
Normal-vs-Stage2
3.847000E-01
Normal-vs-Stage3
3.068600E-01
Normal-vs-Stage4
5.097600E-01
Stage1-vs-Stage2
8.159800E-01
Stage1-vs-Stage3
3.657400E-01
Stage1-vs-Stage4
8.522400E-01
Stage2-vs-Stage3
2.926000E-01
Stage2-vs-Stage4
6.963800E-01
Stage3-vs-Stage4
5.922400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.722600E-01
Normal-vs-AfricanAmerican
5.757400E-01
Normal-vs-Asian
1.606230E-01
Caucasian-vs-AfricanAmerican
8.694600E-01
Caucasian-vs-Asian
1.161600E-01
AfricanAmerican-vs-Asian
1.875800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.194200E-01
Normal-vs-Female
6.107800E-01
Male-vs-Female
5.531000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.558200E-01
Normal-vs-Age(41-60Yrs)
7.874200E-01
Normal-vs-Age(61-80Yrs)
3.135000E-01
Normal-vs-Age(81-100Yrs)
4.415800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.949200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.229800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.700600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.108300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.131720E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.902400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.459600E-01
Normal-vs-Daily Drinker
1.423020E-01
Normal-vs-Weekly Drinker
1.918610E-01
Normal-vs-Occasional Drinker
6.427000E-01
Normal-vs-Social Drinker
5.780400E-01
Non Drinker-vs-Daily Drinker
2.862400E-01
Non Drinker-vs-Weekly Drinker
4.012200E-01
Non Drinker-vs-Occasional Drinker
9.991400E-01
Non Drinker-vs-Social Drinker
7.042000E-01
Daily Drinker-vs-Weekly Drinker
8.272800E-01
Daily Drinker-vs-Occasional Drinker
1.536150E-01
Daily Drinker-vs-Social Drinker
9.624400E-02
Weekly Drinker-vs-Occasional Drinker
2.527800E-01
Weekly Drinker-vs-Social Drinker
1.773010E-01
Occasional Drinker-vs-Social Drinker
5.671400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.402100E-02
Normal-vs-Grade 2
3.378200E-02
Normal-vs-Grade 3
1.307570E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.624800E-01
Grade 1-vs-Grade 3
2.021000E-01
Grade 1-vs-Grade 4
3.402100E-02
Grade 2-vs-Grade 3
6.715600E-01
Grade 2-vs-Grade 4
3.378200E-02
Grade 3-vs-Grade 4
1.307570E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.302200E-01
Normal-vs-NonDiabetic
5.969600E-01
Diabetic-vs-NonDiabetic
9.027200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.335400E-01
Normal-vs-NoPancreatitis
3.130000E-01
Pancreatitis-vs-NoPancreatitis
6.147400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.290600E-01
Normal-vs-N1
6.301800E-01
N0-vs-N1
6.646800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.249000E-01
Normal-vs-TP53-NonMutant
6.898000E-01
TP53-Mutant-vs-TP53-NonMutant
8.461600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
